Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INHALE-15: Iloprost PD-6 to PD-15 Conversion in PAH
NCT00723554Phase 3Terminated
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Jul 2008
- Primary completion
- Aug 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of iloprost in pulmonary arterial hypertension (PAH), sponsored by Actelion Pharmaceuticals Ltd. Started Jul 2008; status: terminated.
02
Drugs
iloprost
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00723554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00723554.